36 related articles for article (PubMed ID: 35006752)
1. Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.
Kakwere H; Ingham ES; Allen R; Mahakian LM; Tam SM; Zhang H; Silvestrini MT; Lewis JS; Ferrara KW
Bioconjug Chem; 2017 Nov; 28(11):2756-2771. PubMed ID: 28956907
[TBL] [Abstract][Full Text] [Related]
2. Self-adjuvant Astragalus polysaccharide-based nanovaccines for enhanced tumor immunotherapy: a novel delivery system candidate for tumor vaccines.
Li N; Zhang Y; Han M; Liu T; Wu J; Xiong Y; Fan Y; Ye F; Jin B; Zhang Y; Sun G; Sun X; Dong Z
Sci China Life Sci; 2024 Apr; 67(4):680-697. PubMed ID: 38206438
[TBL] [Abstract][Full Text] [Related]
3. Melanoma extracellular vesicles inhibit tumor growth and metastasis by stimulating CD8 T cells.
Dan Y; Ma J; Long Y; Jiang Y; Fang L; Bai J
Mol Immunol; 2024 May; 169():78-85. PubMed ID: 38513590
[TBL] [Abstract][Full Text] [Related]
4. Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy.
Prasad S; Cody V; Saucier-Sawyer JK; Saltzman WM; Sasaki CT; Edelson RL; Birchall MA; Hanlon DJ
Nanomedicine; 2011 Feb; 7(1):1-10. PubMed ID: 20692374
[TBL] [Abstract][Full Text] [Related]
5. Dendritic Cell-Based Immunotherapy: The Importance of Dendritic Cell Migration.
Song MS; Nam JH; Noh KE; Lim DS
J Immunol Res; 2024; 2024():7827246. PubMed ID: 38628676
[TBL] [Abstract][Full Text] [Related]
6. Lymph node macrophages drive innate immune responses to enhance the anti-tumor efficacy of mRNA vaccines.
Kubara K; Yamazaki K; Miyazaki T; Kondo K; Kurotaki D; Tamura T; Suzuki Y
Mol Ther; 2024 Mar; 32(3):704-721. PubMed ID: 38243602
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Dendritic Cell Function via Nanoparticle-Induced Cytosolic Calcium Changes.
Cao Z; Yang X; Yang W; Chen F; Jiang W; Zhan S; Jiang F; Li J; Ye C; Lang L; Zhang S; Feng Z; Lai X; Liu Y; Mao L; Cai H; Teng Y; Xie J
ACS Nano; 2024 Mar; 18(10):7618-7632. PubMed ID: 38422984
[TBL] [Abstract][Full Text] [Related]
8. A model of dendritic cell therapy for melanoma.
Depillis L; Gallegos A; Radunskaya A
Front Oncol; 2013; 3():56. PubMed ID: 23516248
[TBL] [Abstract][Full Text] [Related]
9. Programming peptide-oligonucleotide nano-assembly for engineering of neoantigen vaccine with potent immunogenicity.
Xiang Z; Lu J; Rao S; Fu C; Yao Y; Yi Y; Ming Y; Sun W; Guo W; Chen X
Theranostics; 2024; 14(6):2290-2303. PubMed ID: 38646651
[No Abstract] [Full Text] [Related]
10. Recent Advances in
Krasnovskaya OO; Abramchuck D; Erofeev A; Gorelkin P; Kuznetsov A; Shemukhin A; Beloglazkina EK
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298101
[TBL] [Abstract][Full Text] [Related]
11. Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics.
Chakraborty K; Mondal J; An JM; Park J; Lee YK
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986832
[TBL] [Abstract][Full Text] [Related]
12. Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy.
Biri-Kovács B; Bánóczi Z; Tummalapally A; Szabó I
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839774
[TBL] [Abstract][Full Text] [Related]
13. Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes.
Nasser TA; Adel R; Badr A; Teleb M; Bekhit AA; Elkhodairy KA; Abdelhamid AS; Elzoghby AO
ACS Omega; 2023 Feb; 8(5):4491-4507. PubMed ID: 36777563
[TBL] [Abstract][Full Text] [Related]
14. Imaging strategies for monitoring the immune response.
Liu X; Pan L; Wang K; Pan W; Li N; Tang B
Chem Sci; 2022 Nov; 13(44):12957-12970. PubMed ID: 36425502
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Extracellular Vesicle-Mediated Immune Responses against Antigen-Specific Presentation.
Matsuzaka Y; Yashiro R
Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298556
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology.
Pijeira MSO; Viltres H; Kozempel J; Sakmár M; Vlk M; İlem-Özdemir D; Ekinci M; Srinivasan S; Rajabzadeh AR; Ricci-Junior E; Alencar LMR; Al Qahtani M; Santos-Oliveira R
EJNMMI Radiopharm Chem; 2022 Apr; 7(1):8. PubMed ID: 35467307
[TBL] [Abstract][Full Text] [Related]
17. Trp2 Peptide-Assembled Nanoparticles with Intrinsically Self-Chelating
He Z; Jia H; Zheng M; Wang H; Yang W; Gao L; Zhang Z; Xue J; Xu B; Yang W; Xing G; Gao X; Gao F
ACS Appl Bio Mater; 2021 Jul; 4(7):5707-5716. PubMed ID: 35006752
[TBL] [Abstract][Full Text] [Related]
18. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
[TBL] [Abstract][Full Text] [Related]
19. Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy.
Xiang J; Xu L; Gong H; Zhu W; Wang C; Xu J; Feng L; Cheng L; Peng R; Liu Z
ACS Nano; 2015 Jun; 9(6):6401-11. PubMed ID: 26028363
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
